Kataoka Yoko, Fujita Takuya, Fukunaga Kentaro, Hanaoka Jun
Department of Surgery Shiga University of Medical Science Otsu Japan.
Department of General Thoracic Surgery Kohka Public Hospital Kohka Japan.
Respirol Case Rep. 2023 Jul 31;11(9):e01196. doi: 10.1002/rcr2.1196. eCollection 2023 Sep.
p16 has been used as a surrogate marker for human papillomavirus (HPV)-related tumours. However, it remains unclear whether p16 is also a potential marker for pulmonary tumours. Herein, we report the case of an 80-year-old woman with a history of papillary squamous cell carcinoma of the uterine cervix, presenting with a left pulmonary tumour. A bronchoscopic biopsy revealed squamous cell carcinoma with a papillary pattern, which did not rule out pulmonary metastasis from the cervix. Immunohistochemical staining revealed that the cervical tumour was positive for p16, whereas the pulmonary tumour was negative and was effectively diagnosed as primary pulmonary carcinoma.
p16已被用作人乳头瘤病毒(HPV)相关肿瘤的替代标志物。然而,p16是否也是肺肿瘤的潜在标志物仍不清楚。在此,我们报告一例80岁女性,有子宫颈乳头状鳞状细胞癌病史,出现左肺肿瘤。支气管镜活检显示为具有乳头状模式的鳞状细胞癌,不能排除来自宫颈的肺转移。免疫组化染色显示宫颈肿瘤p16阳性,而肺肿瘤为阴性,最终有效诊断为原发性肺癌。